Related Experiment Videos
Data processing and analysis in the Multicenter Morphometric Mammary Carcinoma Project (MMMCP)
J P Baak1, P J van Diest, C Stroet-van Galen
1Department of Pathology, Free University Hospital, Amsterdam, The Netherlands.
Pathology, Research and Practice
|November 1, 1989
Summary
The Multicenter Morphometric Mammary Carcinoma Project (MMMCP) prospectively studies breast cancer parameters in 3000 patients. This research focuses on data acquisition, processing, and analysis for improved prognostic value and reproducibility.
Area of Science:
- Oncology
- Pathology
- Biostatistics
Background:
- Quantitative pathological parameters are routinely assessed in breast cancer.
- The prognostic value and reproducibility of these parameters require prospective validation.
- Large-scale, multicenter studies are essential for robust findings.
Purpose of the Study:
- To prospectively evaluate the prognostic value of routinely assessed quantitative pathological parameters in breast cancer.
- To assess the reproducibility of these quantitative pathological measurements.
- To describe the data acquisition, processing, and analysis framework for a large multicenter project.
Main Methods:
- Prospective study design.
- Inclusion of approximately 3000 breast cancer patients.
- Multicenter data collection across numerous laboratories and hospitals in the Netherlands.
- Detailed description of data collection schemes, database structure, and data processing protocols.
Main Results:
- Data acquisition, processing, and analysis are critical components for this large-scale project.
- The study design facilitates the evaluation of prognostic value and reproducibility.
- The methodology is established for a substantial patient cohort.
Conclusions:
- The Multicenter Morphometric Mammary Carcinoma Project (MMMCP) provides a robust framework for studying breast cancer parameters.
- The project's methodology supports the assessment of prognostic value and reproducibility.
- Standardized data handling is crucial for multicenter oncological research.